Posted on 11/09/2020 11:12:37 AM PST by Red Badger
(J. Tregoning, The Lancet, 2020)
==========================================================================
A new flu vaccine grown in plants has been put to the test in two large-scale clinical trials, a first for vaccine research.
The vaccine contained virus-like particles which resembled circulating flu strains, extracted from native Australian tobacco relatives that were genetically instructed to produce the viral proteins.
The two trials combined involved nearly 23,000 people and the results suggest that the plant-derived vaccine is not only safe, but comparable to current commercial flu vaccines.
"To the best of our knowledge, these studies and the clinical development programme that preceded them are the largest demonstration to date of the potential for a plant-based platform to produce a human vaccine that can be safe, immunogenic, and effective," the research team wrote.
Every year, the vaccines that protect us against influenza have to be reformulated for the next flu season, which is a huge undertaking.
The influenza virus is a chameleon of sorts, constantly changing the protein molecules it displays on its outer surface, and this has researchers feverishly looking for ways to improve our current vaccine technology.
Most influenza vaccines are currently made using virus particles grown in and harvested from chicken eggs or lab-grown cells, which takes months even after scientists work out which flu strains (and surface proteins) they need to target.
Plants, which can be engineered to produce select proteins and cultivated at scale, could be an alternative, helping to boost our capacity to produce seasonal flu vaccines.
The technique might also help to overcome complications encountered in the way current flu vaccines are manufactured that sometimes renders vaccines less effective.
In this system, the researchers used an Australian relative of the tobacco plant, Nicotiana benthamiana, engineered to produce just the outer shell of influenza viruses. These virus-like particles are then extracted and purified under strict conditions to make a flu vaccine.
The researchers tested their plant-derived vaccine in two clinical trials, funded by the Canadian biotech company which developed the technique, and no major safety concerns were reported.
Phase III trials testing safety and efficacy like this are usually one of the last hurdles vaccines need to clear before they can be approved for widespread use.
But keep in mind that even if a flu vaccine is approved as safe and effective, any manufacturer needs to be able to produce millions of doses every year, which could be a challenge for vaccine-producing plants.
The first trial involved more than 10,100 adults from Asia, Europe and North America, aged 18 to 64 years, and it was designed to show that the vaccine could prevent 70 percent of people in the trial from developing flu-like or other respiratory illnesses in one flu season.
Although this high benchmark was not reached in the trial, the vaccine did protect about a third of people from flu strains circulating in the 2017-2018 Northern Hemisphere winter that were a match for the viral particles in this vaccine.
That result might sound low, but the efficacy of commercial flu vaccines often varies year to year depending on how well a vaccine matches the different flu strains circulating that winter.
The researchers concluded, based on data collected during 2017-2018, that their plant-derived vaccine provided a "broadly similar" level of protection as commercial vaccines used in that particularly long flu season, which is a fair result.
The second study recruited another 12,700 people aged 65 years and over. This is quite important because elderly people's immune systems tend to wane with age, making them more vulnerable to contracting infections.
"Like other influenza vaccines, antibody responses to the [plant-derived] vaccine also diminished with age," the researchers said.
The plant-derived vaccine stimulated less of an antibody response in older people, a somewhat expected result, but it did activate a substantial increase in immune cells ready to respond to flu-like infections.
Promisingly, the protection the vaccine granted people from flu-like illnesses in the 2018-2019 flu season was still on par with a commercially available flu vaccine used that season.
"The field of plant-derived vaccines has grown a lot in the past 28 years, since it was first shown [in 1992] that viral proteins could be expressed in plants," John Tregoning, an infectious disease researcher from Imperial College London, said in a commentary about the latest trial results.
"This is the first time a plant vaccine has been tested in a [human] clinical trial," Tregoning added. "It is a milestone for this technology and sows the seeds for other plant-based vaccines and therapeutics."
If all goes well, this research might one day give us another way to manufacture seasonal flu vaccines that could also be scaled up in the event of another flu pandemic.
In their paper, the researchers claim that their plant-based system can produce the first doses of a newly designed flu vaccine within two months of identifying an emerging influenza strain.
But there is likely still a long road ahead navigating regulatory approvals for this vaccine, so watch this space.
The research was published in The Lancet.
Classic Woody Allen “Sleeper” stuff:
“Science has now discovered that tobacco is good for you!”
;-)
the biotech snake oil salesmen are making a killing
I can go back to cigars!! Woo-hoo!
And they said tobacco was bad for you. Live and learn.
Way back when this stuff started, the French used nicotine to fight it.
They were successful, too but you can’t find that now.
NOW they need to “discover” drinking tequila is good for your heart.
Flu? What’s that?
I have been smoking cigars for decades—and I am healthy as an ox.
Heart? What about liver?
Notice how immediately after the election all the headlines have changed. Such as Sludge Report:
COVID MIRACLE?
JAB ‘90%’ PROTECTION
STOCKS ROCKET TO RECORD
If only Joe Camel lived long enough to see this.
Don't worry. Nothing bad will come from this.
Well, Joe and the Camel did..................
I’ve been chewing Copenhagen Snuff for 46 years. It’s a naturally expectorant.
Well, good point! If it’s good for the liver too, that’s a bonus.
A long time ago people were making comments about how bad tobacco is for us. Our pastor said everything God put on earth can be beneficial to us or God wouldn’t have put it here. We just have to find the beneficial purpose for things like tobacco! Voila! Here it is! My dad would be in his 100s now and he was a tobacco salesman from 1940s till he retired in 1970s or 80s. Wish I could tell him about this new discovery!
Great movie SLEEPER!
Another great one is TO ROME WITH LOVE,
and
MIDNIGHT IN PARIS.
Because true science is quantitative, repeatable and verifiable by peer review subject to transparency and ridicule or rebuttal. Science does not require faith or beliefs in an imaginary friend. The political garbage being passed off as science has as much credence as believing speaking to the sky will bring rain.
That's a laugh. Quantum physics. Schroedinger had a zombie cat (neither dead nor alive). I can tell you tales about that cat you would not believe.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.